The American Headache Society Consensus Statement: Update on integrating new migraine treatment into clinical practice

Jessica Ailani MD, Rebecca C. Burch MD,  Matthew S. Robbins MD, on behalf of the Board of Directors of the American Headache Society

Abstract: To incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on using new acute and preventive treatments for migraine in adults.

Interesting feature: Elegantly written article describing American Headache Society’s consensus statement on the guidance for using acute and preventive treatments for migraine. The most up-to-date article comparing the indications and the efficacies of the abortive and preventive treatment modalities for migraine in adults.

A narrative review of the importance of Pharmacokinetics and drug-interactions of preventative therapies in migraine management

Shivang Joshi, Stewart J Tepper,  Sylvia Lucas, Soeren Rasmussen,  Rob Nelson

Objective: To review the pharmacokinetics of major classes of migraine preventives and the clinical implications of drug-drug interactions (DDIs) using these therapies in migraine management.

Interesting feature: Review article emphasizing the risk of drug-drug interactions in migraine patients and highlighting the necessity for custom-tailored clinical management of migraine using evidence-based treatments.

Monckeberg’s Medical Sclerosis as a Cause for Headaches and Facial Pain

Davis C Thomas, Prisly Thomas,  Anilkumar Sivan,  Priyanka Unnam , Ahana Ajayakumar,  Sanjana Santhosh Kumar, Priyanka Kodaganallur Pitchumani,  Mahnaz Fatahzadeh, Nida-E-Haque Mahmud

Purpose of review: Mönckeberg’s medial sclerosis (MMS) is a chronic, non-inflammatory degenerative condition affecting primarily the tunica media of muscular arteries resulting in their calcification. The purpose of this comprehensive review is to describe MMS as it appears in the literature, in the context of headache and facial pain. Understanding the etiopathology, the associated conditions, and the differential diagnoses is important in managing MMS.

Interesting feature: Comprehensive review article discussing a non-inflammatory condition called MMS, that mimics giant cell arteritis, and posing a clinical diagnostic challenge to the orofacial pain clinician. Provides exhaustive review on comparisons of all features

Temporal change in headache and its contribution to risk of developing first-onset TMD in the OPPERA study

Inna E. Tchivileva, Richard Ohrbachc , Roger B. Fillingimd, Joel D. Greenspane, William Maixnerg, and Gary D. Slade

Temporomandibular disorder involves the muscles of mastication, the temporomandibular joint (TMJ), and/or associated orofacial structures [42]. Clinical manifestations include limited jaw movement, noises or locking in the TMJ, and pain aggravated by jaw function, the latter being a necessary criterion for diagnoses of myalgia and TMJ arthralgia. TMD affects 6–10% of women and 3% of men in the US population [24,25], making it the most